Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers divulge SSTR4 agonists for treatment of pain

Feb. 8, 2022

Roche patents new TLR antagonists for autoimmune disease

Feb. 8, 2022

Heterozygous variants in the CD36 gene linked to bleeding phenotypes

Feb. 8, 2022

Antibody DH-1047 shows protection against SARS-related strains and SARS-CoV-2 variants

Feb. 8, 2022

IDP Discovery Pharma presents data on IDP-410 in preclinical glioblastoma

Feb. 8, 2022

Preclinical data presented for ch128.1/IgG1 in NWM hemorrhagic fever

Feb. 8, 2022

Researchers present novel capsule-mediated gastrointestinal mRNA delivery approach

Feb. 8, 2022

Targeting NQO1 shows protective effects in models of diabetic nephropathy

Feb. 8, 2022

LinKinVax signs licensing agreement with Inserm for vaccine platform

Feb. 7, 2022

Dyve and Moffitt collaborate to study buffering agent for transdermal delivery in cancer models

Feb. 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.